Latest filing published 11 Mar 2019 for Stellar Biotechnologies, Inc., €3,310.
Frank R. Oakes appears in our data through filings on Stellar Biotechnologies, Inc. shares, published by SEDI. Over a trading history stretching from 2 September 2015 to 6 March 2019, the count stands at 6 filings.
On the market, this insider has only sold: 2 sales, €5,912 in total. Since January 2019: no purchases and 1 sale on the market.
Most recently, on 11 March 2019, the filings show an open-market sale worth €3,310 in Stellar Biotechnologies, Inc. Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations